Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial | Zendy

Jinxiang Wang | Zendy; Shu-Ming Zhang | Zendy; Xiaohui Li | Zendy; Yao Zhang | Zendy; Zhenyang Xu | Zendy; Bin Cao | Zendy

Open Access

Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial

Author(s) -

Jinxiang Wang,

Shu-Ming Zhang,

Xiaohui Li,

Yao Zhang,

Zhenyang Xu,

Bin Cao

Publication year - 2016

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2016.04.024

Subject(s) - medicine , procalcitonin , antibiotics , exacerbation , randomized controlled trial , population , acute exacerbation of chronic obstructive pulmonary disease , prospective cohort study , visual analogue scale , surgery , sepsis , environmental health , microbiology and biotechnology , biology

The majority of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have low serum procalcitonin (PCT) values. The aim of this study was to determine whether these patients may benefit from antibiotic treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research